Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1

Experimental and Therapeutic Medicine

Volumn 1, Issue 4, 2010, Pages 575-577

  Jankun, Jerzy ^a,b   Skrzypczak Jankun, Ewa ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Heterozygous mutation A15T; PAI 1 deficiency; Plasminogen activator inhibitor

Indexed keywords

ALANINE; CITRATE SODIUM; HEMOGLOBIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THREONINE;

ADULT; AMERICAN INDIAN; AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING TENDENCY; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CASE REPORT; COMA; DISEASE DURATION; DISEASE SEVERITY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTAXIS; EXON; FAMILY HISTORY; FEMALE; GENE MUTATION; GINGIVA BLEEDING; HEMATOCRIT; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MENORRHAGIA; POSTOPERATIVE HEMORRHAGE; PROTEIN SECRETION; RECURRENT DISEASE; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; YOUNG MODULUS;

EID: 79960296168     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000090     Document Type: Article

References (17)

1. Lopes C, Dina C, Durand E and Froguel P: PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population. Diabetologia 46: 1284-1290, 2003.
2. Zhang ZY, Wang ZY, Dong NZ, Bai X, Zhang W and Ruan CG: A case of deficiency of plasma plasminogen activator inhibitor-1 related to Ala15Thr mutation in its signal peptide. Blood Coagul Fibrinolysis 16: 79-84, 2005.
3. Fay WP, Parker AC, Condrey LRand Shapiro AD: Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood 90: 204-208, 1997.
4. Evans PA, Hawkins K, Lawrence M, Barrow MS, Williams PR and Williams RL: Studies of whole blood coagulation by oscillatory shear, thromboelastography and free oscillation rheometry. Clin Hemorheol Microcirc 38: 267-277, 2008.
5. Gallimore MJ, Harris SL, Tappenden KA, Winter Mand Jones DW: Urokinase induced fibrinolysis in thromboelastography: a model for studying fibrinolysis and coagulation in whole blood. JThromb Haemost 3: 2506-2513, 2005.
6. Carr ME Jr, Krishnamurti C and Alving BM: Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis. Thromb Haemost 67: 106-110, 1992.
7. Sugiki M, Maruyama M, Yoshida E, Mihara H, Kamiguti AS and Theakston DG: Enhancement of plasma fibrinolysis in vitro by jararhagin, the main haemorrhagic metalloproteinase in Bothrops jararaca venom. Toxicon 33: 1605-1617, 1995.
8. Jankun J, Aleem AM, Selman SH, et al: Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis. Int JMol Med 20: 683-687, 2007.
9. Kohro S, Yamakage M, Omote T and Namiki A: In vitro effects of propofol on blood coagulability and fibrinolysis by the use of thromboelastograph technique. Acta Anaesthesiol Scand 43: 217-219, 1999.
10. Agren A, Wiman Band Schulman S: Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Blood Coagul Fibrinolysis 18: 657-660, 2007.
11. Perkowska A, Elhasade A, Durlik M, et al: The effect of chronic allograft rejection on plasma regulators of fibrinolysis. Ann Transplant 7: 44-51, 2002.
12. TEG 5000 User's Manual Version 4.2 Software. Haemoscope Corporation, 2006.
13. Jankun J, Aleem AM, Struniawski R, Lysiak-Szydlowska W, Selman SHand Skrzypczak-Jankun E: Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life. Pharmacol Rep 61: 673-680, 2009.
14. Mehta R and Shapiro AD: Plasminogen activator inhibitor type 1 deficiency. Haemophilia 14: 1255-1260, 2008.
15. Schleef RR, Higgins DL, Pillemer E and Levitt LJ: Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. JClin Invest 83: 1747-1752, 1989.
16. Jankun J and Skrzypczak-Jankun E: Yin and yang of the plasminogen activator inhibitor. Pol Arch Med Wewn 119: 410-417, 2009.
17. Repine T and Osswald M: Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review. Clin Appl Thromb Hemost 10: 293-296, 2004.